Douglas Tavares: Clinical Strategies to Reduce Blood Transfusion and Donor Reliance
Douglas Tavares, Adjunct Professor of Business at Florida Southern College, shared a post on LinkedIn:
”Last week, I published ‘Beyond the Red Crisis: American Red Cross Declares Second-Ever National Blood Supply Crisis in Less Than Five Years.’ –
My goal was to provide an overview of the ongoing U.S. blood shortage and advocate for a unified strategy – one that doesn’t rely solely on donors and blood banks, but also leverages existing strategies to avoid and reduce unnecessary blood transfusions and blood product use.
In the article, I outlined three key pillars for reducing transfusion and donor reliance:
- Clinical and Medical Programs
- Advanced Pharmaceuticals
- Medical Devices and Technology
Beyond patient care, addressing blood scarcity presents a significant economic opportunity.
Implementing these alternative strategies requires minimal to no upfront investment – just a shift toward utilizing existing resources more effectively.
To raise awareness and foster informed discussion – especially for those unfamiliar with the full arsenal of blood-sparing options – I’ve compiled a curated list of articles and resources focusing on the first pillar: Beyond the Red Crisis – Part 1/3: Clinical and Medical Programs.
Stay tuned for the upcoming releases:
- Beyond the Red Crisis – Part 2/3: Advanced Pharmaceuticals
- Beyond the Red Crisis – Part 3/3: Medical Devices and Technology”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation